Stay updated on Gilteritinib vs Midostaurin in AML Clinical Trial

Sign up to get notified when there's something new on the Gilteritinib vs Midostaurin in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gilteritinib vs Midostaurin in AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added and the previous revision v3.4.2 was removed from the page history.
    Difference
    0.1%
    Check dated 2026-03-12T00:28:02.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the Record History; the site-wide funding notice and the v3.4.1 revision entry were removed.
    Difference
    0.8%
    Check dated 2026-02-11T14:25:13.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A notice banner about a lapse in government funding was added to the page, and the revision tag changed from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-02-04T10:38:03.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Glossary visibility and color-coded legends (green for additions, red for deletions) have been added to the study record history, and the revision label updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-28T06:36:27.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The record history shows a minor update: a new revision entry v3.3.4 has been added and v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:17:05.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A new version entry 'Revision: v3.3.3' was added to the Study Record Versions list. The 'HHS Vulnerability Disclosure' link was removed from the footer.
    Difference
    0.2%
    Check dated 2025-12-23T10:20:49.000Z thumbnail image

Stay in the know with updates to Gilteritinib vs Midostaurin in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gilteritinib vs Midostaurin in AML Clinical Trial page.